UroToday.com (@urotoday) 's Twitter Profile
UroToday.com

@urotoday

Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology

ID: 21319494

calendar_today19-02-2009 17:36:50

113,113K Tweet

27,27K Followers

6,6K Following

UroToday.com (@urotoday) 's Twitter Profile Photo
UroToday.com
@urotoday

6 days ago

#ProstateCancer efficacy results from a randomized phase 3 evaluation of transdermal estradiol vs LHRH agonists for androgen suppression in M0 prostate cancer. Presented by Ruth Langley, PhD MRC Clinical Trials Unit at UCL. #ESMO24 written coverage by Zach Klaassen > bit.ly/4d6XNLN

#ProstateCancer efficacy results from a randomized phase 3 evaluation of transdermal estradiol vs LHRH agonists for androgen suppression in M0 prostate cancer. Presented by Ruth Langley, PhD <a href="/MRCCTU/">MRC Clinical Trials Unit at UCL</a>. #ESMO24 written coverage by <a href="/zklaassen_md/">Zach Klaassen</a> &gt; bit.ly/4d6XNLN